Brexit uncertainty favors internationally focused pharma professionals

The uncertainty over the state of the pharmaceutical industry following Brexit will favor internationally focused professionals, according to NonStop Recruitment.

With the UK deciding to leave the European Union last month, a number of commentators have suggested that the sector will face ‘immediate challenges’ including the regulation of medicine, funding research and the potential relocation of the European Medicines Agency. NonStop has warned that professionals with internationally focused skill sets, such as foreign languages and wider commercial experience, are likely to be the ones to benefit from this new landscape.

Matt Beedle, team leader within NonStop Pharma, comments: “While we obviously can’t be certain about the future of the market, it seems highly likely that a number of firms will relocate their services to mainland Europe or Ireland, probably to match the relocation of the European Medicines Agency, which is the reason many companies base their operations in London in the first place. This means that these firms will have to move their staff and not everyone is well suited to a role working on foreign shores, for a variety of reasons. Consequently, from our analysis we believe that professionals with an internationally focused skill set are likely to have the best prospects in this new climate.”